Abstract:Objective: the main objective to the research is to synthesis new compounds from the reaction of (2 E )-phenylprop-2-enal (cinnamaldehyde, which is considered a natural product), with five third-generation cephalosporin antibiotics and study their anti-bacterial activity in addition to evaluated their inhibitory effect against IL-1β, TNF-R2, and DNA ligase to determine their usefulness in treating diseases. Methods: First, (2 E )-phenylprop-2-enal (cinnamonaldehyde) was extracted from cinnamon bark, isolated and purified. The resulting aldehyde was then used to react with the primary amine (cephalosporin compounds) by condensation reaction at acidic medium to give Schiff bases, which are the final compounds. Results: The results of testing the new compounds against two types of studied bacteria, one with P. aeruginosa positive and the other with E. coli negative, at three concentrations showed that the two compounds ( IIIb ) and ( IIId ) have high effectiveness, while ( IIIc ) and ( IIIe ) have best results against P. aeruginosa also the molecular modeling study show that ( IIIa ), ( IIIb ), and ( IIId ) have act as inhibitors for DNA ligase, ( IIId ) is the best inhibitor for TNF-R2, ( IIIc ) and ( IIIe ) have high docking-scores DNA ligase, while docking results with IL-1β and TNF-R2 are low. Discussion: The developmental derivatives were subjected to molecular docking to investigate their binding mode; subsequently, derivatives were identified with a maximum docking score. The binding interactions of hits were obtained from pharmaceutical-based screening to investigate with molecular docking studies. Each hit was docked at the active site to the target protein within the defined grid. Conclusions: The compounds were synthesis successfully, and some of the compounds showed their effectiveness against the studied bacteria, and they had good docking-score results with the studied proteins(IL-1β, TNF-R2, and DNA ligase).

Photoaffinity labeling of benzophenone-containing salicylanilide compounds to give an insight into the mechanism in disrupting peptidoglycan formation

Promysalin, a Salicylate-Containing Pseudomonas Putida Antibiotic, Promotes Surface Colonization and Selectively Targets Other Pseudomonas

Synthesis, Antibacterial Activities and Molecular Docking Studies of Peptide and Schiff Bases As Targeted Antibiotics

Antibacterial Drug Leads Targeting Isoprenoid Biosynthesis

Optimizing the structure of (salicylideneamino)benzoic acids: Towards selective antifungal and anti-staphylococcal agents

Design, Synthesis and Molecular Docking of Salicylic Acid Derivatives Containing Metronidazole As a New Class of Antimicrobial Agents

Crystallographic mapping of beta-lactams bound to a D-alanyl-D-alanine peptidase target enzyme

Molecular Recognition Properties of Salicylic Acid-Imprinted Polymers

Design, Synthesis, and Pharmacological Investigation of Iodined Salicylimines, New Prototypes of Antimicrobial Drug Candidates

An arylsulphonamide that targets cell wall biosynthesis in Mycobacterium tuberculosis

Investigating the Interaction of Octapeptin A3 with Model Bacterial Membranes

Synthesis, Spectral Identification of Some New Schiff Bases, and Evaluation of Their Antibacterial Activity and Inhibitory Effect on Proinflammatory Cytokines (IL-1β, TNF), and DNA Ligase

Deciphering pactamycin biosynthesis and engineered production of new pactamycin analogues

Chemical Approach for Investigation of the Structure‐Activity Relationship of Salmycin and Identification of a Glycan‐based Analogue for Drug Resistant Staphylococcus aureus

Boronic acid inhibitors of penicillin-binding protein 1b: serine and lysine labelling agents

Inhibition of Streptococcus pneumoniae autolysins highlight distinct differences between chemical and genetic inactivation

In situ captured antibacterial action of membrane-incising peptide lamellae

TAG‐Assisted Liquid‐Phase Synthesis and Structure Activity Relationship of Macolacin‐Based Side‐to‐Tail Cyclopeptides Antibiotic

The usnic acid derivative peziculone targets cell wall of Gram-positive bacteria revealed by high throughput CRISPRi-seq analysis

Discovery and chemical optimisation of a Potent, Bi-cyclic (Bicycle ) Antimicrobial Inhibitor of PBP3

Synthesis of some novel 1H‐phenanthro [9,10‐d]imidazole derivatives and their Antibacterial and Molecular docking investigation